Lutathera CA 370 MBq/ml
As listed in the register: Lutathera CA 370 MBq/ml, Infusionslösung
·
- Prescription only
- Everything that fits nowhere else, such as contrast media
- Active substance
- Lutetium(177-Lu(CA)) oxodotreotidum
- Made by
- Novartis Pharma Schweiz AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- gastroenteropankreatische neuroendokrine Tumore (GEP‑NET)
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Novartis Pharma Schweiz AG |
|---|---|
| Active substance | Lutetium(177-Lu(CA)) oxodotreotidum |
| Used in | Everything that fits nowhere else, such as contrast media |
| Classification | V10XX04 · Everything that fits nowhere else, such as contrast media |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | Lutathera CA 370 MBq/ml, Infusionslösung |
| Packs | 20.5 - 25 ml |
| Zulassungsnummer | 66580 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.